upstream processing

upstream processing

featured image of Boosting Biopharmaceutical Manufacturing with Real-Time Control

Boosting Biopharmaceutical Manufacturing with Real-Time Control

BIOT

📰 Optimizing Critical Quality Attributes during Processing explores how a cyber-physical system and digital twin can improve biopharmaceutical manufacturing. 💊🔬🚀

featured image of Revolutionizing Biopharmaceutical Market: ICH Q5A R2's Game-Changing Impact

Revolutionizing Biopharmaceutical Market: ICH Q5A R2’s Game-Changing Impact

BIOT

📢 Discover the Impact of ICH Q5A R2 on the Biopharmaceutical Market! ⚙️ Explore development, processing, manufacturing, and more! 🌍

featured image of Unveiling Top Risk Management Strategies in Biotech Industry

Unveiling Top Risk Management Strategies in Biotech Industry

BIOT

📰 Best-Practice Quality Trends: Going Beyond Basics in Risk Management 🌍🧪 Discover the key aspects and insights for a thriving biotech industry! 🔬

featured image of Bioprocess Vendors Predict Recovery in 2024: Here's How

Bioprocess Vendors Predict Recovery in 2024: Here’s How

BIOT

📢 Bioprocess vendors expect a recovery in 2024, despite normalization dragging on. 🧪💧🏭🔬💼

featured image of 2024: The Year of Breakthroughs in Bioprocessing?

2024: The Year of Breakthroughs in Bioprocessing?

BIOT

Will 2024 be the year of breakthroughs in bioprocessing? 🌟 Find out in this insightful article! Bioprocessing2024

featured image of AGC Invests $350M+ to Build Mammalian Plant in Japan: Boosting Biopharma Manufacturing

AGC Invests $350M+ to Build Mammalian Plant in Japan: Boosting Biopharma Manufacturing

BIOT

💰 AGC, a Japanese pharmaceutical company, plans to invest over $350 million in a new mammalian cell culture plant in Chiba, Japan. 🏭 This plant will produce cell cultures for biopharmaceutical manufacturing, strengthening AGC's position in the market. 🧪 Construction to be completed by 2022.

featured image of Upstream vs Downstream Productivity: Who Will Win?

Upstream vs Downstream Productivity: Who Will Win?

BIOT

📢 Will downstream productivity catch up with the upstream in 2024? Discover how the bioprocessing industry tackles challenges and embraces opportunities. ⏭️👥🌍